04.04.2011 • News

Solvay Bids €3.4 Billion for France's Rhodia

Belgian chemicals and plastics maker Solvay said on Monday it will buy French chemicals company Rhodia, valuing the firm at €3.4 billion and ending a year-long hunt for a takeover deal.

Solvay, which sold its drugs unit to its U.S. partner Abbott Laboratories in September 2009 for €4.5 billion, said it would bid €31.60 per share for Rhodia in a deal that was unanimously recommended by Rhodia's board of directors.

The offer price constitutes a premium of 50% compared to the latest closing share price of Rhodia, giving an enterprise value of €6.6 billion and a recurring earnings before interest, tax, depreciation and amortization of 7.3 times.

Solvay said the acquisition of Rhodia will be earnings accretive from the first year and the deal will be fully financed by the company's cash resources.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.